Katić, K.; Katić, J.; Kumrić, M.; Božić, J.; Tandara, L.; Šupe Domić, D.; Bućan, K.
The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema. Diagnostics 2024, 14, 992.
https://doi.org/10.3390/diagnostics14100992
AMA Style
Katić K, Katić J, Kumrić M, Božić J, Tandara L, Šupe Domić D, Bućan K.
The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema. Diagnostics. 2024; 14(10):992.
https://doi.org/10.3390/diagnostics14100992
Chicago/Turabian Style
Katić, Karla, Josip Katić, Marko Kumrić, Joško Božić, Leida Tandara, Daniela Šupe Domić, and Kajo Bućan.
2024. "The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema" Diagnostics 14, no. 10: 992.
https://doi.org/10.3390/diagnostics14100992
APA Style
Katić, K., Katić, J., Kumrić, M., Božić, J., Tandara, L., Šupe Domić, D., & Bućan, K.
(2024). The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema. Diagnostics, 14(10), 992.
https://doi.org/10.3390/diagnostics14100992